Sartorius Xpress Biologics SA
76.2 FTESartorius Xpress Biologics reported revenue of €2.41m for the 2025 financial year (annual accounts filed with the NBB on 13 Apr 2026), with 76.2 full-time equivalents.
By total assets for 2025, Sartorius Xpress Biologics ranks among the 50 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Sartorius Xpress Biologics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +139 % Total assets +19 % Headcount (avg FTE) +102 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sartorius Xpress Biologics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €2.41m | ||||
| Net result | −€6.50m | ||||
| Equity | −€9.49m | ||||
| Cash | 0 € | ||||
| EBITDA | −€4.72m | ||||
| Total assets | €10.9m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Apr 2026
- Year ended 31 Dec 2024filed on 09 Apr 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 26 May 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
Sartorius Xpress Biologics's financial analysis
- Solvency-86.9%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sartorius Xpress Biologics
Sartorius Xpress Biologics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0550.686.915
- VAT number
- BE0550686915
- Peppol
- Registered · 0208:0550686915 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Apr 2014
- Registered office
- 4041 Herstal
- Size
- Medium · 76.2 FTE
- Latest accounts
- 2025 · filed on 13 Apr 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Sartorius Xpress Biologics (SA) has been based in Herstal since 2014, active in: manufacture of basic pharmaceutical products. For 2025, it reports revenue of €2.41m, a net loss of €6.50m and equity of −€9.49m. With 76.2 full-time equivalents, it is a medium-sized enterprise by headcount.
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Sartorius Xpress Biologics
Companies in the same business, of comparable size and area, outside its group.
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
- ATB Therapeutics Manufacture of basic pharmaceutical products Marche-en-Famenne · balance sheet €10.6m
- Shant Biotech Manufacture of basic pharmaceutical products Tubize · balance sheet €11.0m
- Phoenix Biosciences Manufacture of pharmaceutical preparations Nivelles · balance sheet €8.11m
- EXO Biologics Research and experimental development on natural sciences and engineering Liège · balance sheet €11.7m
- Unisensor Manufacture of basic pharmaceutical products Seraing · balance sheet €19.2m
- LaCAR MDx technologies Manufacture of other special-purpose machinery n.e.c. Liège · balance sheet €29.1m
- Immunodiagnostic Systems Manufacture of other chemical products n.e.c. Liège · balance sheet €10.7m
Frequently asked questions about Sartorius Xpress Biologics
What is the revenue of Sartorius Xpress Biologics?
According to the 2025 annual accounts filed with the NBB, the revenue of Sartorius Xpress Biologics amounts to 2,406,103 €.
What is the VAT number of Sartorius Xpress Biologics?
In Belgium, the VAT number is the company number prefixed with BE: BE0550686915 for Sartorius Xpress Biologics, if the company is VAT-registered. Its company number (CBE) is 0550.686.915.
Where is the registered office of Sartorius Xpress Biologics?
According to the CBE register, the registered office of Sartorius Xpress Biologics is in 4041 Herstal.
What is the equity of Sartorius Xpress Biologics?
At the close of the 2025 financial year, the equity of Sartorius Xpress Biologics amounts to -9,487,789 €, a solvency of -86.9% of total assets.
How many people work at Sartorius Xpress Biologics?
76.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sartorius Xpress Biologics?
The register lists 3 active mandates at Sartorius Xpress Biologics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Sartorius Xpress Biologics within its sector?
By total assets for 2025, Sartorius Xpress Biologics ranks among the 50 largest of the 327 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of Sartorius Xpress Biologics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →